Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer : recommendations from the International Society of Geriatric Oncology (SIOG)In: The Lancet Oncology , Jg. 26 2025, Nr. 2, S. e90 – e102
-
Risk beyond neutropenia : insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantationIn: Journal of Leukocyte Biology (JLB) , Jg. 117 2025, Nr. 2, qiae250
-
Cellular therapies in older adults with hematological malignancies : A case-based, state-of-the-art reviewIn: Journal of Geriatric Oncology , Jg. 15 2024, Nr. 3, 101734DOI (Open Access)
-
Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphomaIn: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 12, e009462DOI (Open Access)
-
Three-Year Mortality of Older Hospitalized Patients with Osteosarcopenia : Data from the OsteoSys StudyIn: Nutrients , Jg. 16 2024, Nr. 9, 1328DOI (Open Access)
-
Training needs of German healthcare professionals regarding sexual health and sex workers : results of a nationwide, cross-sectional surveyIn: BMC Medical Education , Jg. 24 2024, Nr. 1, 1557DOI (Open Access)
-
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myelomaIn: Frontiers in Oncology , Jg. 13 2023, 1168120DOI (Open Access)
-
Attitudes towards sex workers : A nationwide cross-sectional survey among German healthcare providersIn: Frontiers in Public Health , Jg. 11 2023, 1228316DOI (Open Access)
-
Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's WitnessIn: ASAIO Journal , Jg. 69 2023, Nr. 8, S. e384 – e387DOI (Open Access)
-
Hypomethylating agent-based therapies in older adults with acute myeloid leukemia : A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee CommitteeIn: Journal of Geriatric Oncology , Jg. 14 2023, Nr. 3, 101406DOI (Open Access)
-
Treating acute myelogenous leukemia in patients aged 70 and above : Recommendations from the International Society of Geriatric Oncology (SIOG)In: Journal of Geriatric Oncology , Jg. 15 2023, Nr. 2, 101626DOI (Open Access)
-
“Celebrating Resilience” : A review of abstracts on functional resilience at the International Society of Geriatric Oncology 2022 annual meetingIn: Journal of Geriatric Oncology , Jg. 14 2023, Nr. 7, 101587
-
How we use noncancer-specific survival prediction in geriatric oncology : A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiativeIn: Journal of Geriatric Oncology , Jg. 13 2022, Nr. 4, S. 516 – 520
-
News and hot topics in geriatric medicine that are of interest for geriatric oncologists : Insights from the 17th EuGMS meeting 2021 – A report from Young SIOG
17th European Geriatric Medicine Congress: EuGMS 2021, 11.-14.10.2021, Athen, Online,In: Journal of Geriatric Oncology , Jg. 13 2022, Nr. 5, S. 758 – 760 -
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairmentsIn: Journal of Cachexia, Sarcopenia and Muscle , Jg. 13 2022, Nr. 1, S. 264 – 275DOI, Online Volltext (Open Access)
-
Frailty assessment in the care of older people with haematological malignanciesIn: The Lancet Healthy Longevity , Jg. 2 2021, Nr. 11, S. e736 – e745DOI (Open Access)
-
S3-Leitlinie der deutschsprachigen Gesellschaften für Geriatrie zum „Umfassenden Geriatrischen Assessment im Krankenhaus“ – die Erste ihrer Art
Gemeinsamer Jahreskongress der Deutschen Gesellschaft für Gerontologie und Geriatrie (DGGG) und der Deutschen Gesellschaft für Geriatrie (DGG) „Altern ohne Grenzen“, 11.–14. September 2024, Kassel,In: Zeitschrift für Gerontologie und Geriatrie , Jg. 57 2024, Nr. 2, S. 112 -
Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 Trial
The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,In: Blood , Jg. 144 2024, Nr. Supplement 1, S. 4498DOI (Open Access) -
A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood , Jg. 142 2023, Nr. Supplement 1, S. 6248 – 6251DOI (Open Access) -
Kardiale KOmorbiditäten und KOmplikationen beim geriatrisch-hämatologischen Patienten : ein K.O.- Kriterium?
Gemeinschaftskongress der Deutschen Gesellschaft für Gerontologie und Geriatrie (DGGG) und der Deutschen Gesellschaft für Geriatrie (DGG) ; „Altern im Spannungsfeld von Resilienz und Vulnerabilität“ ; 12.–15. September 2022, Frankfurt am Main, Germany,In: Zeitschrift für Gerontologie und Geriatrie , Jg. 55 2022, Nr. Suppl. 1: Abstracts des Gerontologie und Geriatrie Kongresses 2022 „Altern im Spannungsfeld von Resilienz und Vulnerabilität“, S. S63DOI (Open Access) -
Venetoclax and Hypomethylating Agents Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th Annual Meeting, S. 12943 – 12944DOI (Open Access) -
Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 193DOI (Open Access)